Cargando…

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia

BACKGROUND: Multiple system atrophy (MSA) may develop levodopa-induced dyskinesia, which is dystonic and predominant in the orofacial region. We aimed to characterize the patterns of presynaptic dopaminergic degeneration in patients with MSA and dyskinesia using (123)I-N-x-fluoropropyl-2b-carbo-meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueno, Shin-ichi, Oyama, Genko, Kanai, Kazuaki, Hatano, Taku, Shimo, Yasushi, Hattori, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394229/ https://www.ncbi.nlm.nih.gov/pubmed/32775020 http://dx.doi.org/10.5334/tohm.58

Ejemplares similares

Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
por: Nishikawa, Noriko, et al.
Publicado: (2022)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
por: Bautista, Juan Miguel Pilar, et al.
Publicado: (2020)

Myalgia caused by chronic myositis associated with plasmacytosis: a case report
por: Hatano, Taku, et al.
Publicado: (2018)

A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson's Disease
por: Sekimoto, Satoko, et al.
Publicado: (2019)

White matter and nigral alterations in multiple system atrophy-parkinsonian type
por: Ogawa, Takashi, et al.
Publicado: (2021)

Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey
por: Ogawa, Mayuko, et al.
Publicado: (2022)

Validity of Single Tract Microelectrode Recording in Subthalamic Nucleus Stimulation
por: Umemura, Atsushi, et al.
Publicado: (2013)

Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia
por: Nakamura, Takuto, et al.
Publicado: (2019)

Motor/Nonmotor Symptoms and Progression in Patients with Parkinson's Disease: Prevalence and Risks in a Longitudinal Study
por: Yoritaka, Asako, et al.
Publicado: (2020)

Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules
por: Ogawa, Takashi, et al.
Publicado: (2020)

Cerebral microbleeds and blood pressure abnormalities in Parkinson's disease
por: Yamashiro, Kazuo, et al.
Publicado: (2017)

Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report
por: Kamo, Hikaru, et al.
Publicado: (2019)

Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans
por: Herz, Damian M., et al.
Publicado: (2015)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

Short-Term Motor Outcomes in Parkinson's Disease after Subthalamic Nucleus Deep Brain Stimulation Combined with Post-Operative Rehabilitation: A Pre-Post Comparison Study
por: Sato, Kazunori, et al.
Publicado: (2022)

Neurocognitive and psychiatric disorders‐related axonal degeneration in Parkinson's disease
por: Andica, Christina, et al.
Publicado: (2020)

The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson’s disease
por: Tanaka, Ryota, et al.
Publicado: (2020)

Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson’s disease model mice
por: Handa, Kazuaki, et al.
Publicado: (2019)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease
por: Nakamura, Ryota, et al.
Publicado: (2023)

White matter microstructures in Parkinson's disease with and without impulse control behaviors
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2022)

LOW DOSE LEVODOPA IN TARDIVE DYSKINESIA
por: Sethi, Sujata, et al.
Publicado: (1990)

Involvement of Autophagy in Levodopa‐Induced Dyskinesia
por: Feyder, Michael, et al.
Publicado: (2021)

Clinical Aspects and Management of Levodopa-Induced Dyskinesia
por: Tambasco, Nicola, et al.
Publicado: (2012)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
por: Zheng, Chang-Qing, et al.
Publicado: (2021)

Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
por: Ogawa, Takashi, et al.
Publicado: (2018)

Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism
por: Monnot, Cyril, et al.
Publicado: (2017)

Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

Vitamin B6 Deficiency Anemia Attributed to Levodopa/Carbidopa Intestinal Gel Therapy for Parkinson's Disease: A Diagnostic Pitfall for Myelodysplastic Syndrome with Ring Sideroblasts
por: Yasuda, Hajime, et al.
Publicado: (2022)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
por: Krishnan, Syam, et al.
Publicado: (2017)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
por: Yoo, Han Soo, et al.
Publicado: (2019)

Levodopa-induced belly dancer's dyskinesia: Case report
por: Cavalcante-Filho, José Renan Miranda, et al.
Publicado: (2020)

Paroxysmal Kinesigenic Dyskinesia-like Symptoms in a Patient with Tourette Syndrome
por: Oyama, Genko, et al.
Publicado: (2011)

Current Topics in Deep Brain Stimulation for Parkinson Disease
por: UMEMURA, Atsushi, et al.
Publicado: (2016)

Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson's Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)
por: Sato, Kazunori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mfuqabpjsmm4up0n6qc29ap7me